VanHimbergen Robert M 4

What Happened
Robert M. VanHimbergen, EVP and Chief Financial Officer of Elanco Animal Health (ELAN), was granted 8.32 deferred stock units on April 17, 2026. The units are recorded at $23.68 each for a total grant value of about $197. This transaction is coded as an award/grant (derivative), not an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-04-17; 8.32 units @ $23.68 each (total ≈ $197).
• Transaction type/code: Award/Grant (A); these are derivative deferred stock units, not immediate shares.
• Footnotes: F1 — each deferred stock unit equals the right to one share or the cash equivalent; F2 — units settle in cash or shares after employment termination or in a specified future year under the Executive Deferral and Stock Match Plan.
• Shares owned after transaction: not specified in the provided filing details.
• Filing: Form 4 filed Apr 21, 2026 (within the SEC’s two-business-day filing window for this Apr 17 transaction).

Context
Deferred stock units are a form of compensation that convert to shares or cash at a later date and are common for executives; they do not represent an immediate buy or sell of company stock and therefore are less informative about short-term sentiment than open-market purchases or sales. This grant is small in dollar value (~$197) and appears to be a routine compensation/deferral event.